News - Powered by Yahoo NewsEvotec AG and 4-Antibody AG Form Strategic Collaboration to Innovate Antibody Selectio
HAMBURG, Germany and BASEL, Switzerland -- Evotec AG (TecDAX) and 4-Antibody AG today announced the signing of a strategic collaboration agreement under which Evotec will offer a fully integrated antibody ...
Tue, 08 May 2012 22:49:24 -0700 -
DGAP-News: Evotec AG and 4-Antibody AG form strategic collaboration to innovate antibody selectio
DGAP-News: Evotec AG / Key word(s): AllianceEvotec AG and 4-Antibody AG form strategic collaboration to innovateantibody selection09.05.2012 / 07:27* EVOTEC AND 4-ANTIBODY LAUNCH NEW HIGH CONTENT SCREENING PLATFORM FOR EARLYANTIBODY FUNCTIONALITY ?
Tue, 08 May 2012 22:46:29 -0700 -
AnaptysBio Announces Antibody Discovery Partnership With Gilead Science
SAN DIEGO, May 1, 2012 /PRNewswire/ -- AnaptysBio, Inc., a privately-held therapeutic antibody company, today announced an antibody discovery partnership with Gilead Sciences, Inc. to develop novel antibody ...
Tue, 01 May 2012 05:00:00 -0700 -
Theraclone Sciences Announces Positive Top-line Data from a Phase 1 Trial of its Therapeutic Antibody Directed at ..
Theraclone Sciences, Inc., a therapeutic antibody discovery and development company, today announced positive top-line data from its Phase 1 trial of TCN-032, a broadly protective, fully human monoclonal antibody, being developed for the treatment of influenza A infections.
Tue, 15 May 2012 06:00:00 -0700 -
SPRead Your Antibody Capabilitie
Using surface plasmon resonance to improve antibody detection and characterization: four case studies
Thu, 03 May 2012 06:23:41 -0700 -
biOasis Transcend Vector Delivers an Anti-Amyloid Beta
VANCOUVER, BRITISH COLUMBIA-- - biOasis Technologies Inc. today announces test results from its Transcend therapeutic development program directed towards the delivery of targeted therapeutic compounds ...
Tue, 08 May 2012 06:00:00 -0700 - (AB) Antibody To The Brain
Cell Signaling Technology, Inc. Develops Novel Monoclonal Antibody Discovery Platfor
Cell Signaling Technology, Inc. of Danvers, MA is pleased to announce the development of a new discovery platform for antigen-specific monoclonal antibodies. This novel antibody discovery technology, named NG-XMTTM, harnesses the power of proteomics to identify and clone antigen-specific monoclonal antibodies directly from the circulating serum of an immunized animal.
Fri, 11 May 2012 04:00:00 -0700 -
Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of ..
BOTHELL, Wash., May 7, 2012 /PRNewswire/ -- Alder BioPharmaceuticals Inc. today announced the initiation of a Phase 1 clinical study of its antibody therapeutic candidate, ALD403, targeting the calcitonin ...
Mon, 07 May 2012 05:00:00 -0700 -
/C O R R E C T I O N -- Amgen
In the news release, Amgen's BiTEŽ Antibody Blinatumomab (AMG 103) Achieved High Rate of Complete Response in Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, issued 16-May-2012 ...
Fri, 18 May 2012 17:00:00 -0700 -
Van Andel Research Institute and Dako sign agreement to license cancer diagnostic too
( Van Andel Research Institute ) Van Andel Research Institute and Dako, the Danish-based, worldwide supplier of cancer diagnostic tools today announce an agreement to license, manufacture and distribute cancer diagnostics utilizing the MET4 Antibody.
Thu, 17 May 2012 06:50:28 -0700 -